Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleGroup for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2017 Annual Meeting Amsterdam, the Netherlands

The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting

Niti Goel, Denis O’Sullivan, Maarten de Wit, Chris A. Lindsay, Heidi Bertheussen, John Latella, Jeffrey Chau, Roland MacDonald, Suzanne Grieb, Ingrid Steinkoenig and Willemina Campbell
The Journal of Rheumatology Supplement June 2018, 94 52-53; DOI: https://doi.org/10.3899/jrheum.180138
Niti Goel
From the Advisory Services, IQVIA, Adjunct Assistant Professor, Duke University School of Medicine, Durham, North Carolina; International Dermatology Outcome Measurers, Windsor, Connecticut; Johns Hopkins University School of Medicine, Center for Child and Community Health Research, Baltimore, Maryland; Cleveland Clinic, Cleveland, Ohio, USA; Our Lady’s Hospice and Care Services, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands; Biomedical Laboratory Scientist, Oslo University Hospital, Oslo, Norway; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; Toronto Western Hospital, Psoriatic Arthritis Clinic, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: niti.goel@iqvia.com
Denis O’Sullivan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten de Wit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris A. Lindsay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi Bertheussen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Latella
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Chau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland MacDonald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Grieb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Steinkoenig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willemina Campbell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has reached the third of 5 stages of organizational maturity regarding incorporating patient research partners (PRP) into psoriatic arthritis (PsA) and psoriasis research and educational efforts. Herein, we report the involvement of PRP at the GRAPPA 2017 annual meeting and plans for future PRP engagement.

Key Indexing Terms:
  • PSORIATIC ARTHRITIS
  • PATIENT RESEARCH PARTNERS
  • PATIENT CENTRICITY
  • GRAPPA
  • PSORIASIS
  • ORGANIZATIONAL MATURITY

Over the last 5 years, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has made substantial progress to incorporate patient input into the group’s work. As a result, the GRAPPA patient research partner (PRP) network has evolved in parallel. Herein, the PRP network’s involvement since the GRAPPA 2016 annual meeting and their evolution as a group since their first formal attendance at the GRAPPA 2013 annual meeting are summarized.

PRP Involvement at the GRAPPA 2017 Annual Meeting

Premeeting

Twelve PRP who attended the GRAPPA 2017 annual meeting were educated on the Core Outcome Measures for Psoriatic Arthritis Clinical Trials (COMPACT) study. They then participated in focus groups to evaluate the content validity and feasibility of selected patient-reported outcome measurements. The summary of this premeeting is planned to be presented separately. Generally, such collaboration between patients and researchers should improve researcher understanding of the effect of psoriatic arthritis (PsA) on patients and patient priorities regarding outcomes. Subsequently, the PRP, including 1 who attended by Skype, and the PRP Executive Liaison met to evaluate an initial draft of the PRP Policies and Procedures document.

During the GRAPPA 2017 meeting, PRP were present at all sessions. They participated in breakout groups that built upon the premeeting work to evaluate instrument content validity and feasibility. During the GRAPPA project update session, PRP shared how their membership has progressed (Table 1). From 2013 through 2017, 16 PRP had attended at least 1 meeting, and 3 PRP had consecutively attended all 5 annual meetings since 2013.

View this table:
  • View inline
  • View popup
Table 1.

Evolution of PRP attendance at annual GRAPPA meetings from 2013 to 2017.

PRP Involvement in GRAPPA Activities

Since the GRAPPA 2016 annual meeting, PRP have continued to be involved in multiple projects, including several activities related to the Outcome Measures in Rheumatology-GRAPPA update of the PsA core set, the COMPACT study, the composite measures consensus meeting, the PsA treatment guidelines slide deck, the GRAPPA mobile device application, the GRAPPA research proposals review, and the GRAPPA Collaborative Research Network. In addition, PRP are planning how best to disseminate the PRP-generated booklet, A Patient’s Guide to Treatments for Psoriatic Arthritis.

Reflecting upon the PRP premeeting work, PRP shared with the general GRAPPA membership that the PRP network is creating a governance document to dovetail with the current GRAPPA bylaws, and that they plan to create a PRP handbook to provide additional details. Further, the GRAPPA Executive Committee assigned an Executive Liaison to facilitate the PRP network.

These latter activities highlight how the GRAPPA PRP network may be operating close to the third level of organizational maturity, the “Defined” maturity level, in the Capability Maturity Model Integration (CMMI) model (Table 2)1,2. This model, originally used to define best practices related to software development, has been expanded to help organizations improve their processes at all levels from services to people.

View this table:
  • View inline
  • View popup
Table 2.

Capability Maturity Model Integration organization maturity levels.

The GRAPPA PRP network has not undergone any formal process improvement procedures and may not be the type of organization intended to undergo a CMMI assessment. However, as the PRP network continues to develop, achieving a state similar to those described in levels 4 and 5 of the CMMI model might signal that PRP themselves start to lead the investigation of their own questions related to psoriatic disease as considered at the GRAPPA 2016 annual meeting3.

PRP are actively defining their participation within the GRAPPA community. As their role evolves within the organization, the benefits realized from their contributions to GRAPPA initiatives will hopefully be recognized and grow. The PRP appreciate their involvement in GRAPPA and anticipate a future where incorporating patient input into research and educational endeavors is routine.

Acknowledgments

We thank Rodrigo Firmino, PhD, Professor, Pontifical Catholic University of Parana, Curitiba, Brazil, for his participation in this patient research partners effort.

Footnotes

  • As part of the supplement series GRAPPA 2017, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards.

REFERENCES

  1. 1.↵
    What is Capability Maturity Model Integration (CMMI)? [Internet. Accessed February 14, 2018.] Available from: cmmiinstitute.com/capability-maturity-model-integration
  2. 2.↵
    1. CMMI Product
    . CMMI for Service, Version 1.3, CMMI-SVC V.1.3 CMU/SEI-2010-TR034, Technical Report, Software Engineering Institute, 2010.
  3. 3.↵
    1. Goel N,
    2. O’Sullivan D,
    3. Steinkoenig I,
    4. James J,
    5. Lindsay CA,
    6. Coates LC,
    7. et al.
    Tackling patient centricity: a report from the GRAPPA 2016 Annual Meeting. J Rheumatol 2017;44:703–5.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology Supplement
Vol. 94
1 Jun 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting
Niti Goel, Denis O’Sullivan, Maarten de Wit, Chris A. Lindsay, Heidi Bertheussen, John Latella, Jeffrey Chau, Roland MacDonald, Suzanne Grieb, Ingrid Steinkoenig, Willemina Campbell
The Journal of Rheumatology Supplement Jun 2018, 94 52-53; DOI: 10.3899/jrheum.180138

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Patient Research Partner Network Matures: A Report from the GRAPPA 2017 Annual Meeting
Niti Goel, Denis O’Sullivan, Maarten de Wit, Chris A. Lindsay, Heidi Bertheussen, John Latella, Jeffrey Chau, Roland MacDonald, Suzanne Grieb, Ingrid Steinkoenig, Willemina Campbell
The Journal of Rheumatology Supplement Jun 2018, 94 52-53; DOI: 10.3899/jrheum.180138
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • PRP Involvement at the GRAPPA 2017 Annual Meeting
    • PRP Involvement in GRAPPA Activities
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

PSORIATIC ARTHRITIS
PATIENT RESEARCH PARTNERS
PATIENT CENTRICITY
GRAPPA
PSORIASIS
ORGANIZATIONAL MATURITY

Related Articles

Cited By...

More in this TOC Section

  • GRAPPA Trainees Symposium 2017: A Report from the GRAPPA 2017 Annual Meeting
  • The Role of the Microbiome in Gut and Joint Inflammation in Psoriatic Arthritis and Spondyloarthritis
Show more Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2017 Annual Meeting Amsterdam, the Netherlands

Similar Articles

Keywords

  • psoriatic arthritis
  • PATIENT RESEARCH PARTNERS
  • PATIENT CENTRICITY
  • GRAPPA
  • psoriasis
  • ORGANIZATIONAL MATURITY

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire